Transgene Biotek Limited (BOM:526139)
India flag India · Delayed Price · Currency is INR
3.110
-0.020 (-0.64%)
At close: Jun 5, 2026

Transgene Biotek Statistics

Total Valuation

BOM:526139 has a market cap or net worth of INR 235.64 million. The enterprise value is 406.40 million.

Market Cap235.64M
Enterprise Value 406.40M

Important Dates

The next estimated earnings date is Thursday, August 13, 2026.

Earnings Date Aug 13, 2026
Ex-Dividend Date n/a

Share Statistics

BOM:526139 has 75.77 million shares outstanding. The number of shares has decreased by -0.84% in one year.

Current Share Class 75.77M
Shares Outstanding 75.77M
Shares Change (YoY) -0.84%
Shares Change (QoQ) +0.52%
Owned by Insiders (%) 33.21%
Owned by Institutions (%) 8.28%
Float 50.61M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 65.26
PB Ratio 2.81
P/TBV Ratio 12.81
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -24.59
EV / Sales 112.55
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.08, with a Debt / Equity ratio of 2.05.

Current Ratio 0.08
Quick Ratio 0.01
Debt / Equity 2.05
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -0.56

Financial Efficiency

Return on equity (ROE) is -17.96% and return on invested capital (ROIC) is -2.32%.

Return on Equity (ROE) -17.96%
Return on Assets (ROA) -0.26%
Return on Invested Capital (ROIC) -2.32%
Return on Capital Employed (ROCE) -0.45%
Weighted Average Cost of Capital (WACC) 7.72%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.00
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -22.25% in the last 52 weeks. The beta is 1.00, so BOM:526139's price volatility has been similar to the market average.

Beta (5Y) 1.00
52-Week Price Change -22.25%
50-Day Moving Average 2.85
200-Day Moving Average 3.20
Relative Strength Index (RSI) 52.80
Average Volume (20 Days) 43,666

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, BOM:526139 had revenue of INR 3.61 million and -16.53 million in losses. Loss per share was -0.22.

Revenue3.61M
Gross Profit 3.61M
Operating Income -5.93M
Pretax Income -16.53M
Net Income -16.53M
EBITDA -3.94M
EBIT -5.93M
Loss Per Share -0.22
Full Income Statement

Balance Sheet

The company has 608,000 in cash and 171.37 million in debt, with a net cash position of -170.76 million or -2.25 per share.

Cash & Cash Equivalents 608,000
Total Debt 171.37M
Net Cash -170.76M
Net Cash Per Share -2.25
Equity (Book Value) 83.77M
Book Value Per Share 1.10
Working Capital -122.29M
Full Balance Sheet

Cash Flow

Operating Cash Flow -113,000
Capital Expenditures n/a
Depreciation & Amortization 1.99M
Net Borrowing 6.98M
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -164.14%
Pretax Margin -457.74%
Profit Margin n/a
EBITDA Margin -109.00%
EBIT Margin -164.14%
FCF Margin n/a

Dividends & Yields

BOM:526139 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 0.84%
Shareholder Yield 0.84%
Earnings Yield -7.01%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2